REVVITY, INC (RVTY) Operating Margin
- Operating margin · 12 months: Value 12.32%; Formula and calculation Operating income / revenue. Period ending 2026-07-05..
Operating margin
Overview →Financial period ending 2026-07-05; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 12.32% | Operating income / revenue. Period ending 2026-07-05. $358.85M ÷ $2.91B × 100 ≈ 12.32% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 358.85M USD | Operating Income (Loss) |
| Revenue | 2.91B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 215.83M USD | Research and Development Expense |
| Selling, general and administration | 1.03B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-07-05 | $358.85M | $2.91B | (m) | $215.83M | $1.03B | 12.32% |
| 2026-04-05 | $360.29M | $2.90B | (m) | $220.13M | $996.05M | 12.41% |
| 2025-12-28 | $356.63M | $2.86B | (m) | $215.84M | $991.89M | 12.49% |
| 2025-09-28 | $363.64M | $2.81B | (m) | $206.87M | $984.49M | 12.93% |
| 2025-06-29 | $379.89M | $2.80B | (m) | $205.22M | $980.10M | 13.57% |
| 2025-03-30 | $374.86M | $2.77B | (m) | $200.08M | $983.22M | 13.53% |
| 2024-12-29 | $346.74M | $2.76B | (m) | $196.84M | $994.07M | 12.59% |
| 2024-09-29 | $305.15M | $2.72B | (m) | $197.23M | $1.01B | 11.21% |
| 2024-06-30 | $276.23M | $2.71B | (m) | $201.13M | $1.02B | 10.20% |
| 2024-03-31 | $268.56M | $2.73B | (m) | $210.25M | $1.03B | 9.85% |
| 2023-12-31 | $300.56M | $2.75B | (m) | $216.58M | $1.02B | 10.93% |
| 2023-10-01 | $360.87M | $2.80B | (m) | $221.52M | $1.01B | 12.91% |
| 2023-07-02 | $402.42M | $2.84B | (m) | $222.00M | $1.00B | 14.19% |
| 2023-04-02 | $556.86M | $3.02B | (m) | $220.78M | $998.81M | 18.42% |
| 2023-01-01 | $742.70M | $3.31B | (m) | $221.62M | $1.03B | 22.43% |
| 2022-10-02 | $979.00M | $4.84B | (m) | $302.30M | $1.31B | 20.24% |
| 2022-07-03 | $1.04B | $5.02B | (m) | $298.89M | $1.36B | 20.67% |
| 2022-04-03 | $1.12B | $5.02B | (m) | $291.36M | $1.31B | 22.30% |
| 2022-01-02 | $1.33B | $5.07B | (m) | $274.97M | $1.23B | 26.29% |
| 2021-10-03 | $1.53B | $5.06B | (m) | $251.47M | $1.14B | 30.30% |
| 2021-07-04 | $1.56B | $4.85B | (m) | $232.99M | $1.02B | 32.10% |
| 2021-04-04 | $1.40B | $4.44B | (m) | $216.69M | $960.74M | 31.58% |
| 2021-01-03 | $978.58M | $3.78B | (m) | $205.39M | $917.89M | 25.87% |
| 2020-10-04 | $606.58M | $3.23B | (m) | $196.20M | $865.58M | 18.76% |
| 2020-07-05 | $437.23M | $2.98B | (m) | $191.45M | $844.50M | 14.69% |
| 2020-04-05 | $353.32M | $2.89B | (m) | $190.27M | $825.03M | 12.24% |
| 2019-12-29 | $361.97M | $2.88B | (m) | $189.34M | $815.32M | 12.55% |
| 2019-09-29 | $339.41M | $2.83B | $1.46B | $193.67M | $815.12M | 11.97% |
| 2019-06-30 | $340.95M | $2.80B | $1.44B | $197.14M | $807.72M | 12.17% |
| 2019-03-31 | $337.28M | $2.78B | $1.43B | $195.99M | $811.04M | 12.12% |
| 2018-12-30 | $323.88M | $2.78B | $1.44B | $194.00M | $811.91M | 11.66% |
| 2018-09-30 | $310.97M | $2.66B | (m) | $179.70M | $767.90M | 11.68% |
| 2018-07-01 | $308.81M | $2.54B | (m) | $165.74M | $723.90M | 12.14% |
| 2018-04-01 | $294.93M | $2.39B | (m) | $152.10M | $668.88M | 12.36% |
| 2017-12-31 | $304.80M | $2.26B | (m) | $139.40M | $616.17M | 13.50% |
| 2017-10-01 | $287.82M | $2.18B | (m) | $134.66M | $606.69M | 13.19% |
| 2017-07-02 | $283.80M | $2.14B | (m) | $129.29M | $598.43M | 13.25% |
| 2017-04-02 | $274.07M | $2.13B | (m) | $127.59M | $601.44M | 12.86% |
| 2017-01-01 | $283.07M | $2.12B | (m) | $124.28M | $600.88M | 13.38% |
| 2016-10-02 | $305.91M | $2.27B | (m) | $132.00M | $605.84M | 13.49% |
| 2016-07-03 | $300.58M | $2.28B | (m) | $129.92M | $607.77M | 13.17% |
| 2016-04-03 | $297.52M | $2.27B | (m) | $127.59M | $600.52M | 13.08% |
| 2016-01-03 | $286.13M | $2.26B | (m) | $125.93M | $598.85M | 12.65% |
| 2015-10-04 | $231.98M | $2.26B | (m) | $126.86M | $656.99M | 10.25% |
| 2015-06-28 | $214.85M | $2.24B | (m) | $126.21M | $652.26M | 9.59% |
| 2015-03-29 | $216.36M | $2.23B | (m) | $123.88M | $652.77M | 9.69% |
| 2014-12-28 | $210.74M | $2.24B | (m) | $121.14M | $659.34M | 9.42% |
| 2014-09-28 | $262.75M | $2.23B | (m) | $123.39M | $587.52M | 11.79% |
| 2014-06-29 | $261.93M | $2.21B | (m) | $124.35M | $587.30M | 11.86% |
| 2014-03-30 | $232.27M | $2.19B | (m) | $128.29M | $587.56M | 10.59% |
| 2013-12-29 | $217.44M | $2.17B | (m) | $133.02M | $585.85M | 10.04% |
| 2013-09-29 | $101.92M | $2.15B | (m) | $133.86M | $624.61M | 4.75% |
| 2013-06-30 | $87.94M | $2.13B | (m) | $134.73M | $626.40M | 4.13% |
| 2013-03-31 | $98.06M | $2.11B | (m) | $134.19M | $627.38M | 4.65% |
| 2012-12-30 | $98.54M | $2.12B | (m) | $132.64M | $632.73M | 4.66% |
| 2012-09-30 | $103.53M | $2.08B | (m) | $130.60M | $674.98M | 4.97% |
| 2012-07-01 | $96.45M | $2.03B | (m) | $128.30M | $662.66M | 4.76% |
| 2012-04-01 | $86.08M | (m) | (m) | $122.26M | $651.33M | (m) |
| 2012-01-01 | $91.13M | $1.92B | (m) | $115.82M | $627.17M | 4.74% |
| 2011-10-02 | $159.36M | $1.85B | $1.03B | $110.33M | $534.94M | 8.61% |
| 2011-07-03 | $166.57M | $1.82B | $1.01B | $103.91M | $520.39M | 9.17% |
| 2011-04-03 | $162.32M | $1.76B | $975.00M | $98.67M | $503.63M | 9.23% |
| 2011-01-02 | $153.60M | $1.70B | $945.72M | $95.41M | $490.66M | 9.01% |
| 2010-10-03 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-07-04 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-04-04 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-01-03 | $121.92M | $1.55B | $851.78M | $90.78M | $468.29M | 7.86% |
| 2009-10-04 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-07-05 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-28 | $147.63M | $1.66B | $925.97M | $93.03M | $486.37M | 8.89% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |